Medirom Healthcare Reports August 2024 KPIs
Ticker: MRM · Form: 6-K · Filed: Sep 24, 2024 · CIK: 1819704
Sentiment: neutral
Topics: kpi, press-release, operational-update
TL;DR
Medirom Healthcare dropped its August 2024 KPIs on 9/24.
AI Summary
Medirom Healthcare Technologies Inc. announced its Key Performance Indicators (KPIs) for August 2024 via a press release on September 24, 2024. The filing is a Form 6-K report.
Why It Matters
This filing provides investors with updated operational metrics for Medirom Healthcare Technologies Inc., allowing for a timely assessment of the company's performance.
Risk Assessment
Risk Level: low — This is a routine filing providing operational updates, not a material event like an acquisition or financial distress.
Key Players & Entities
- Medirom Healthcare Technologies Inc. (company) — Filer of the report
- September 24, 2024 (date) — Date of press release and filing
- August 2024 (date) — Period for which KPIs are reported
FAQ
What specific Key Performance Indicators (KPIs) were announced for August 2024?
The filing states that a press release was issued announcing major Key Performance Indicators (KPIs) for August 2024, but the specific KPIs are not detailed within the provided text of the 6-K itself, only that they are in Exhibit 99.1.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on September 24, 2024.
What is the primary purpose of this Form 6-K filing?
The primary purpose is to report the issuance of a press release by Medirom Healthcare Technologies Inc. announcing its updated Key Performance Indicators (KPIs) for August 2024.
Does this filing contain financial statements?
No, this filing is a Report of Foreign Private Issuer and specifically states it contains information regarding the issuance of a press release about KPIs, not full financial statements.
What is the company's principal executive office address?
The company's principal executive office is located at 2-3-1 Daiba, Minato-ku, Tokyo 135-0091, Japan.
Filing Stats: 272 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2024-09-24 06:05:09
Filing Documents
- tmb-20240924x6k.htm (6-K) — 15KB
- tmb-20240924xex99d1.htm (EX-99.1) — 97KB
- tmb-20240924xex99d1001.jpg (GRAPHIC) — 5KB
- tmb-20240924xex99d1003.jpg (GRAPHIC) — 49KB
- tmb-20240924xex99d1004.jpg (GRAPHIC) — 59KB
- tmb-20240924xex99d1005.jpg (GRAPHIC) — 50KB
- tmb-20240924xex99d1006.jpg (GRAPHIC) — 44KB
- tmb-20240924xex99d1007.jpg (GRAPHIC) — 52KB
- tmb-20240924xex99d1008.jpg (GRAPHIC) — 53KB
- tmb-20240924xex99d1009.jpg (GRAPHIC) — 50KB
- 0001558370-24-012975.txt ( ) — 614KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. MEDIROM HEALTHCARE TECHNOLOGIES INC. Date: September 24, 2024 By: /s/ Fumitoshi Fujiwara Name: Fumitoshi Fujiwara Title: Chief Financial Officer